- Home
- WULF vs NVCR Comparison
WULF vs NVCR Comparison
Compare WULF & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WULF
- NVCR
- Stock Information
- Founded
- WULF 1952
- NVCR 2000
- Country
- WULF United States
- NVCR Jersey
- Employees
- WULF N/A
- NVCR N/A
- Industry
- WULF EDP Services
- NVCR Medical/Dental Instruments
- Sector
- WULF Technology
- NVCR Health Care
- Exchange
- WULF Nasdaq
- NVCR Nasdaq
- Market Cap
- WULF 1.6B
- NVCR 1.8B
- IPO Year
- WULF 1995
- NVCR 2015
- Fundamental
- Price
- WULF $6.95
- NVCR $17.39
- Analyst Decision
- WULF Strong Buy
- NVCR Buy
- Analyst Count
- WULF 8
- NVCR 5
- Target Price
- WULF $6.03
- NVCR $26.60
- AVG Volume (30 Days)
- WULF 26.6M
- NVCR 1.3M
- Earning Date
- WULF 11-12-2024
- NVCR 10-30-2024
- Dividend Yield
- WULF N/A
- NVCR N/A
- EPS Growth
- WULF N/A
- NVCR N/A
- EPS
- WULF N/A
- NVCR N/A
- Revenue
- WULF $120,247,000.00
- NVCR $549,964,000.00
- Revenue This Year
- WULF $129.08
- NVCR $16.23
- Revenue Next Year
- WULF $87.70
- NVCR $6.09
- P/E Ratio
- WULF N/A
- NVCR N/A
- Revenue Growth
- WULF 197.49
- NVCR 8.33
- 52 Week Low
- WULF $0.89
- NVCR $10.87
- 52 Week High
- WULF $7.28
- NVCR $24.74
- Technical
- Relative Strength Index (RSI)
- WULF 69.41
- NVCR 43.24
- Support Level
- WULF $6.41
- NVCR $15.61
- Resistance Level
- WULF $7.28
- NVCR $17.31
- Average True Range (ATR)
- WULF 0.55
- NVCR 1.29
- MACD
- WULF 0.17
- NVCR 0.05
- Stochastic Oscillator
- WULF 82.04
- NVCR 11.59
About WULF TeraWulf Inc.
TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. The company's primary focus is supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. The company's primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.